MLEC · Moolec Science SA
United States · RS rating 2 · As of 2026-10-14
| Price | 1.87 USD |
|---|---|
| 1-day change | +9.4% |
| RS rating (overall / 1M / 3M / 12M) | 2 / 1 / 2 / 5 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 13 / 15 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -20.0% |
| Sales growth Q/Q | +69.8% |
| Distance from 52-week high | +89.1% |
| Market cap (USD) | $5.2M |